GL Ventures, Temasek co-lead $230m round in China's Clover Biopharmaceuticals

GL Ventures, Temasek co-lead $230m round in China's Clover Biopharmaceuticals

Photo: National Cancer Institute/Unsplash

23 February, 2021

biotech Clover Biopharmaceuticals GL Ventures Temasek vaccine

Printed by Unregistered user on Fri, 18 Jul 2025 23:32:05 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Policy & Regulations

Indonesia lifts some foreign investment restrictions to boost COVID-hit economy

China’s Sinovac secures $515m to boost COVID-19 vaccine production

Read more from Greater China

Policy & Regulations

Chinese automakers should pursue ‘rational competition’ in EV industry

Venture Capital

China’s CAS Star hits first close of new hard tech fund